---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-008492"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2024-03-01T23:59:59+00:00"
generated_at: "2026-06-05T05:39:00.471520+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions engages C2C and ClearThink for IR and advisory services

## Summary
- C2C Advisors agreement: $25K/month cash + 37,500 restricted shares for 6-month term.
- ClearThink Capital agreement: 5,260 initial restricted shares + $5K/month cash + $4K/month in restricted stock.
- Shares issued under Section 4(a)(2) exemption from registration.
- Both agreements for advisory and investor relations services; C2C term 6 months, ClearThink ongoing until terminated after 3 months.

## SEC filing metadata
- accession: 0001493152-24-008492
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2024-03-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315224008492/0001493152-24-008492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315224008492/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-008492
- JSON: https://secwatch.observer/filing/0001493152-24-008492.json
- Plain text: https://secwatch.observer/filing/0001493152-24-008492.txt

## Key facts
- Material Agreements
  INTELLIGENT BIO SOLUTIONS INC. entered into Consulting Agreement with C2C Advisors Inc. valued at $25,000 per month (effective 2024-02-29).
  - Action: entry
  - Counterparty: C2C Advisors Inc.
  - Value: $25,000 per month
  - Effective: 2024-02-29
  source text: On February 29, 2024, Intelligent Bio Solutions Inc. (the “Company”) entered into a Consulting Agreement (the “C2C Agreement”) with C2C Advisors Inc. (“C2C”) pursuant to which C2C will provide certain advisory and investor relations services to the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315224008492/0001493152-24-008492-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.